Molbio Diagnostics unveils Truenat HPV-HR Plus, aims to enhance cervical cancer screening The new test covers eight high-risk HPV genotypes, including 52 and 58 — now detectable at the point-of-care
HPV remains largely misunderstood by general public: Roche Survey Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with…
Accelerate efforts to eliminate cervical cancer by 2030: WHO Prioritising cervical cancer elimination worldwide, cervical cancer remains grave threat to women’s lives
